Abzu, founded in Copenhagen in 2018, built the QLattice, which its EIC report calls "Abzu's unique, explainable AI". Explainable AI produces results whose reasoning people can inspect. Abzu's EIC project aimed to build a "Human-Centric AI platform" for health and life sciences.
The European Innovation Council granted €2,495,099 towards a €3.6 million project from January 2023 to December 2024. The final report says the QLattice was refined and "integrated it with transformers and specialized tools for RNA therapeutics", that its Python interface had been installed nearly 40,000 times and that 235 publications cited it. In 2024 the company made its first positive gross profit, DKK 5.3 million, and cut its loss to DKK 3.8 million, according to Proff. In April 2026 Abzu ApS was declared bankrupt.
Company file
- Legal entity
- Abzu ApS, CVR 39248530, Nordhavn (Copenhagen)
- Founded
- 2018
- Product
- QLattice explainable AI; Feyn Python interface; RNA therapeutics tools
- Staff
- 20 in 2023, 12 in 2024
- EIC project
- HCAI4ALL, 1 Jan 2023 to 31 Dec 2024, closed
- EIC funding
- Grant first
- Insolvency
- Declared bankrupt April 2026
What Happened to Abzu
The bankruptcy was registered in mid-April 2026. In July 2026 the auction house Auktionshuset dab sold the estate's office furniture and electronics. No accounts for 2025 were published before the bankruptcy, and no buyer for the QLattice technology has been announced. Abzu's reasons for failing have not been made public.
The Technology: AI You Can Read
The EIC project combined the QLattice with transformer models, the architecture behind today's large language models, and built specialised tools for RNA therapeutics. Researchers cited the QLattice in 235 publications, 40 of them citing the main paper, according to the report.
What the EIC Project Promised, and What CORDIS Shows
HCAI4ALL was to turn the QLattice into a human-centric AI platform for health and life sciences. The report shows the technical work done and wide use of the free library. It gives no figures on paying customers or revenue.
- Refined QLatticeDeliveredPer final report.
- RNA therapeutics toolsDeliveredPer final report.
- AdoptionWide use~40,000 installs.
- A viable companyFailedBankrupt April 2026.
The Money
Abzu lost DKK 8.2 million in 2020, DKK 15.3 million in 2021, DKK 17.9 million in 2022 and DKK 13.2 million in 2023. In 2024 gross profit turned positive for the first time and the loss fell to DKK 3.8 million, but equity had shrunk from DKK 21.3 million in 2021 to DKK 7.0 million, and staff from 20 to 12.
What Cannot Be Checked
Questions for the EIC
Why Abzu failed after improving its results in 2024, what happened in 2025, who now owns the QLattice and its patents, and what creditors will recover are not public.
Why Europe Should Care
The EIC paid for Abzu to adapt its version to medicine, and the work was delivered and widely used. The company behind it did not survive.
What the project promised
A human-centric, explainable AI platform for health and life sciences.
What the record shows
The platform built, 40,000 library installs, a first gross profit in 2024, then bankruptcy in April 2026.
The Verdict
Delivered, then dissolved
Abzu did what the EIC paid for and was moving towards break-even in 2024. Sixteen months after the project closed, the company was bankrupt and its furniture was being auctioned.
Abzu's bankruptcy estate and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.
